Dr. Hoyos Velez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1102 Bates Ave
17th Floor
Houston, TX 77030Phone+1 713-873-2000
Summary
- I am a physician-scientist board certified in Internal Medicine and Medical Oncology, involved in research focused on improving cellular immunotherapies for the treatment of cancer. During my research training, I acquired the skills necessary to design viral vectors to genetically manipulate cells for the generation of novel cancer treatments. My clinical interests lie in treating patients with breast cancer, and my current research goal is to develop effective T cell therapies against new tumor specific targets and incorporate strategies to overcome the hostile breast tumor microenvironment. My long-term goal is to translate these therapies into the clinic, to give breast cancer patients the opportunity to benefit from them.
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2014 - 2017
- Baylor College of MedicineResidency, Internal Medicine, 2009 - 2014
- Pontifical Xavierian UniversityClass of 2006
Certifications & Licensure
- TX State Medical License 2012 - 2025
- MD State Medical License 2014 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CPRIT Scholar Cancer Prevention & Research Institute of Texas, 2017
Publications & Presentations
PubMed
- 75 citationsCAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activationPradip Bajgain, Supannikar Tawinwung, Lindsey D’Elia, Sujita Sukumaran, Norihiro Watanabe
Journal for Immunotherapy of Cancer. 2018-05-10 - 53 citationsThe immunotherapy era of myeloma: monoclonal antibodies, vaccines and adoptive T cell therapiesValentina Hoyos, Ivan Borrello
Blood. 2016-09-29 - 48 citations3D modeling of human cancer: A PEG-fibrin hydrogel system to study the role of tumor microenvironment and recapitulate the in vivo effect of oncolytic adenovirus.Francesca Del Bufalo, Teresa Manzo, Valentina Hoyos, Shigeki Yagyu, Ignazio Caruana
Biomaterials. 2016-04-01
Professional Memberships
- Associate
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: